Assess the Mid-term Performance of the Mpact Cup in Subjects Requiring Total Hip Arthroplasty

A Multi-centre, Prospective Post Marketing Surveillance Study to Assess Mid-term Performance of the Mpact Cup in Subjects Requiring Primary Total Hip Arthroplasty

Monitor the performance of the Mpact cup in the treatment of patients with hip joint disease requiring a total hip replacement.

Inclusion Criteria:

• Patients who are willing and able to provide written informed consent for participation in the study. Written informed consent must be obtained prior to the patient's surgery.

  • Those presenting with disease that meets the indications for use for Medacta USA implants defined by this study (on-label use).
  • Patients must be willing to comply with the pre and post-operative evaluation schedule

Exclusion Criteria:

• Those with one or more medical conditions identified as a contraindication defined by the labeling on any Medacta implants used in this study.